4 models fit Methanex Corporation Common Stock and they disagree: 1 of 4 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Bronze57
Valued as a cyclical company: P/E comparison, EV/EBITDA comparison, Discounted cash flow, and Graham number.
ACCE opinionMethanex Corporation Common Stock (MEOH)
Fair value (4 models)
$33.29
ACCE price target
$63.00
Rating
Overvalued
Horizon
12 months
Fair value published on 18 Oct 2026, 16:04 CEST; previously $31.69 since 14 Oct 2026, 00:00 CEST.
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 16:04 CEST.
Price used: $63.08 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
89.5% above
-47.2% to fair value
ACCE score
77
out of 100
Analysts
70% buy
10 covering
P/E
62.5x
forward 10.4x
1-year return
+75.6%
Dividend yield
1.22%
Methanex Corporation Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Methanex is one of the world's largest producers of methanol, a commodity chemical that goes into formaldehyde resins, acetic acid and increasingly fuel and power applications, with plants spread across North America, Trinidad and the Middle East. Its advantage is scale and cost position: it is a low-cost, integrated producer selling into a market where the marginal ton sets the price, so volume and natural gas spreads drive earnings more than anything the company does on its own. Trailing earnings look thin, with a P/E of 64.3 against a forward P/E of 10.4, which tells you the market is pricing a sharp recovery in methanol margins rather than the current year's depressed numbers. Revenue growth of 75.2% reflects a rebound in pricing and volumes off a weak base, and the 37.1% operating margin shows how much operating leverage sits in the business when prices move. The stock is worth a closer look if you have a view on methanol pricing and gas costs over the next two to three years, since the forward multiple depends entirely on that call, and the 6.1% ROE says the balance sheet and cycle have not yet translated into durable returns.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
high
Earnings driven by spike
Revenue grew 75.2% YoY and earnings 164.7%, but 5y revenue CAGR is only 6.3%. Trailing P/E of 64.3 versus forward P/E of 10.4 suggests the current year is well above normal.
moderate
Leverage elevated
Debt/Equity of 1.44 is high for a commodity chemicals producer. Net margin of 2.1% leaves little cushion if the earnings spike reverses.
moderate
Price above model fair value
The stock trades 89.5% above the model fair value of $33.29. It also sits 0.1% above the ACCE price target of $63.00, which was last updated 2026-10-10.
AI research notes
AI-assisted·How I use AIWritten Oct 18, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 75.2% year over year, far faster than its 6.3% average annual pace over five years.
Free cash flow of $732M over the last twelve months gives a 14.6% free cash flow yield at today's price.
Seven of ten analysts rate the stock Buy or Strong Buy, and their mean target sits 9.6% above the share price.
Why it could disappoint
The share trades 89.5% above the model fair value of $33.29, and all four valuation models sit below the price.
Net margin of 2.1% and return on invested capital of 1.1% show the revenue surge is not yet turning into profit.
Debt to equity of 1.44 and a 7.5% rise in the diluted share count leave shareholders with a thinner claim on earnings.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Oct 29, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where MEOH's valuation models land
Price
$63.08
Model fair value
$33.29
Model range
$26.53 to $47.03
Fair value $33.29
Price $63.08
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores